OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2020-12-31-accounts

THE INSULIN DEPENDENT DIABETES TRUST

Registered Number: 3148360 Charity Number: 1058284


THE INSULIN DEPENDENT DIABETES TRUST

_____________

TRUSTEES’ REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

THE INSULIN DEPENDENT DIABETES TRUST

CONTENTS

Page
Charity Information 1
Trustees’ Report 2 - 9
Independent Examiner’s Report
10
Statement of financial activities 11
Balance sheet 12
Notes to the financial statements 13 - 25

THE INSULIN DEPENDENT DIABETES TRUST

CHARITY INFORMATION

Trustees

Trustees
Mrs J M D Hirst MBE, Co-Chair
Dr M Kiln, Co-Chair
Dr L Gerlis, Medical Adviser
Ms A Aubin
Ms C Baker
Mr J Birbeck
Mrs G Coleman
Mrs L Ingram
Mrs V Readman
Dr R Rijckborst
Company registered
number 3148360
Charity registered
number 1058284
Registered office 210 Abington Avenue
Northampton
Northamptonshire
NN1 4PR
Non-executive
director Dr Gary Adams
Bankers Yorkshire Bank
7 Gold Street
Northampton
NN1 1EN
Investment advisors MPA
98 High Street
Henley in Arden
B95 5BY
Accountants Paul Slater & Co
1 Washington Street
Northampton
NN2 6NN

1

THE INSULIN DEPENDENT DIABETES TRUST

TRUSTEES’ REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

Company and banking details etc

The Trustees present their annual report together with the financial statements of the Insulin Dependent Diabetes Trust (IDDT) for the year 1 January 2020 to 31 December 2020. The Annual report serves the purpose of both a Trustees’ report and a directors’ report under company law. The Trustees confirm that the Annual report and financial statement of the charitable company comply with the current statutory requirements, the requirements of the charitable company’s governing document and the provision of the Statement of Recommended Practice (SORP) applicable to charities preparing their accounts in accordance with the Financial Reporting Standard in the UK and Republic of Ireland.

Since the Company qualified as small under section 382 of the Companies Act 2006, the Strategic report of medium and large companies under the Companies Act 2006 (Strategic Report and Directors’ regulations 2013) have been omitted.

Objectives and activities

a. Policies and objectives

In setting and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit, including the guidance ‘Public benefit, running a charity (PB2)’.

b. Strategies for achieving objectives

The purposes of the charity as set out in its governing document remain unchanged:

c. Activities undertaken to achieve the objectives

In view of the Covid-19 pandemic, the Trustees recognised that while the purposes of the charity remain the same, some of our activities to achieve the aims and objectives had to be reduced or suspended. However, to the best of our ability, the following activities were carried out:

2

THE INSULIN DEPENDENT DIABETES TRUST

d. Social Investment policies

The charity continued to operate the policies and procedures document relating to fundraising and sponsorship for the Trust approved in 2015. The interest generated continues to assist in supporting the charities causes.

e. Grant-making policies

The Trust has made the decision to support one large 5 year study at Nottingham University which is investigating the action of insulin. However, in the middle of 2020 this funding was suspended to safeguard the financial future of the charity due to the financial uncertainties caused by the pandemic.

f. Main activities undertaken to further the Charity’s purposes for the public benefit

The Charity works hard to promote various ways people can live with diabetes and lead a fulfilled and happy life. Our booklets, leaflets and newsletters all extend help and support and our helpline offers one to one assistance.

Achievements and performance

a. Main achievements of the Charity

The main achievements during 2020 have been as follows:

Financial

3

THE INSULIN DEPENDENT DIABETES TRUST

Membership

Footcare

Leaflets, booklets, Newsletters and Type 2 & You

b. Key performance indicators

The Key performance indicators include:

c. Review of activities

During 2020, the health professional conferences that the Charity usually attends were postponed due to the pandemic and the deposits paid were held over until 2021, assuming they are able to be held in 2021. It remains to be seen whether these conferences will go ahead or whether they will be cost effective for the charity. However, our advertising in professional journals continued and resulted in requests for leaflets and booklets which were much appreciated.

4

THE INSULIN DEPENDENT DIABETES TRUST

IDDT continues to keep an international presence, especially for people outside the UK who need to use animal insulin. There have been increased problems in obtaining animal insulin in some countries due to changes in regulations and Brexit, so the countries have worked together to rectify this. Providing information and support to people with diabetes wherever they live forms an important part of the charity’s activities.

It is with regret that as the UK arm of Insulin for Life, we have had to a hold on collecting unwanted insulin and other diabetes items during the major part of 2020 to send to help people in Tanzania because during the pandemic our contacts were lost and parcels did not arrive at their destination. This is likely to continue for the foreseeable future, but the Trustees would like to thank the individuals and hospitals that have tried to make donations of unwanted items.

The charity’s ‘Sponsor a Child’ scheme to help children and young adults at Dream Trust in India continues to flourish and the Trustees and Dr Pendsey at Dream Trust thank everyone for their continued support of families in need. Dream Trust has made financial donations to help particularly needy families during the pandemic.

d. Factors relevant to achieve objectives

The short and longer term aims and objectives

e. Fundraising activities and income generation

The Charity relies on grant aid from donors identified in the accounts and the Trustees are most appreciative of this support. There are minor fundraising activities which include Christmas card sales, books, aids to help with caring for the feet and Recycle for Charity.

f. Investment policy and performance

The Trustees have resolved to establish reserves for future activities and they have wide powers of investment. The policy on reserves is that establishing assets are retained to produce income, income which is wholly used to support existing activities. There is no intention in the long-term to either increase or reduce the capital held. The policy is justified in that it is necessary to preserve income at present levels in order to maintain the activities of the charity.

During 2020, the investment income was significantly lower than previous years due to the economic climate, again justifying this policy of safeguarding the charity’s future.

5

THE INSULIN DEPENDENT DIABETES TRUST

Financial review

a. Going concern

The operations and business activities of the Charity has been impacted by the COVID-19 outbreak. However, after making appropriate enquiries, the Trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.

b. Reserves policy

IDDT complies with Charity Commission Guidelines

IDDT has a Research and Welfare Fund

Short-term investments

We invest some funds in 6 and 12 monthly Bonds in order to ensure that the charity has rapid access to funds in case the day-to-day income is lower than expected. If this is not the case, then the Bonds are rolled over for further 6 and 12 month periods.

Long-term investments

We have 5 to 10 year investments. These are monitored through our investment portfolios and with regular meetings with our Financial Advisers. All investments have the facility for easy access to funds.

Cash reserves

All legacy income is paid into IDDT’s Legacy account and transfers are made as/when necessary to the current account for running expenses.

Day to day income

Cash, cheques and credit cards are paid into the current account with the Yorkshire Bank. Standing order payments are paid into a Barclays Bank current account and transferred into the Yorkshire current account on a regular basis.

Lottery income

The Lottery income is paid into a stand-alone account and the profits paid into the Yorkshire Bank account on a regular basis.

c. Principle risks and uncertainties

The Trustees cannot find any major risks to which the charity is exposed each financial year when preparing and updating the strategic plan, in particular those relating to operations and finances of the charity.

A risk register has been established. Procedures are in place to ensure compliance with health and safety of staff and visitors to the offices. Internal control risks are minimised by the implementation of procedures for the authorisation for all transactions and projects.

6

THE INSULIN DEPENDENT DIABETES TRUST

d. Principal funding

The principal sources of income are from legacies and voluntary donations. The Trustees are aware of the need to generate regular income and are continuing to take steps to achieve this. The Trustees are very grateful for the continued generosity of the members in making donations and especially to the increasing numbers of people who make regular donations through their bank. They also wish to record their gratitude to the donors of legacies and donations in memory of loved ones for their kindness in helping other people with diabetes.

The Trustees would also like to express their thanks for the continuing support and help of members and their families which provides encouragement to the Trustees to continue with the aims and objectives of IDDT. This support reflects the needs of people living with diabetes to be represented by a patient/carer-based charity that understands their needs and remains independent and uninfluenced by outside financial influences.

Considering the small numbers of members of staff and the amount of work covered, the Trustees would like to thank the staff for their continued dedication and hard work during 2020.

The Trustees reaffirm their commitment and determination to try to ensure that people with diabetes and their families have informed choices of treatment, and access to them, that they deserve and need. While evidence from national audits suggests that there are some improvements in the care and treatment of Type 1 and Type 2 diabetes in the NHS, there are many improvements yet to be made. The Trustees are committed to try to raise awareness of this, influence policy makers to bring about the necessary improvements and to encourage those with diabetes to insist on receiving the care they need.

Structure, governance and management

a. Constitution

The Insulin Dependent Diabetes Trust is registered as a charitable company limited by guarantee and was set up by a Memorandum of Association.

b. Methods of appointment or election of Trustees

The directors of the company are also charitable Trustees for the purposes of charity law and under the company’s Articles of Association are known as the Board of Trustees. Under the requirements of the Memorandum and Articles of Association the members of the Board of Trustees are elected to serve for a period of three years, after which they must be re-elected at the next Annual Meeting.

Due to the nature of the work of the charity and the importance of understanding the needs of and representation of people with diabetes and their families, at no time shall the number of Trustees who are medically qualified or are allied health professionals exceed twenty five per cent of the total number of Trustees. The charity records the particular skills of the Trustees in order to maintain a broad mix of skills and expertise.

c. Organisational structure and decision-making policies

A Board of a maximum of 11 Trustees administer the charity, covering policy, membership and finances. Minor day to day decisions are taken by the Co-Chairs and CEO. Modern technology enables consultations to be made easily and quickly. Major decisions on future policies are taken at the AGM for the approval of members.

During 2020, some members of the staff team have changed and the team now consists of one full time member and three part-time people with temporary help being employed as necessary. This is a reduction of one part-time member of staff compared to 2019 and this situation will be reviewed when the pandemic situation becomes clearer. The charity will continue to update staff skills when

7

THE INSULIN DEPENDENT DIABETES TRUST

required to ensure their skills and knowledge remain relevant and up to date. The Charity contracts out the website work, PR and press releases, IT support and day to day finances.

The charity continued to operate the policies and procedures document relating to fundraising and sponsorship for the Trust approved in 2015. The day to day running of the charity is carried out by the CO-Chairs and CEO.

d. Policies adopted for the induction and training of the Trustees

The Trustees are familiar with the practical work of the charity. New Trustees are encouraged to take short training sessions to familiarise themselves with:

e. Pay policy for key management personnel

IDDT has two key management personnel

There is a line management structure in place.

Pay Reviews

The Trustees review staff salaries for the following year at their November meeting. The general principle is to give pay increases in line with inflation.

f. Related party relationships

The Charity maintains its links with people and groups in other countries around the world. The charity continues to offer support and information to people in other countries, especially those in need of animal insulin. Providing information and support wherever people live continue to be a major role.

The Trustees wish to thank Wockhardt UK for their ongoing supply of porcine insulin in vials and cartridges. As the only known supplier in the world, IDDT is aware of the vulnerable position this is for people who need porcine insulin because of adverse effects when using synthetic GM insulins.

Plans for future periods

The Charity’s strategies for achieving its aims and objectives in the future

THE INSULIN DEPENDENT DIABETES TRUST

Statement of Trustees’ responsibilities

The Trustees (who are also directors of the Company for the purposes of company law) are responsible for preparing the Trustees’ report and financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year. Under Company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and its incoming resources and application of resources, including income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Company’s transactions and disclose with reasonable accuracy at any time the financial position of the Company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence taking reasonable steps for the prevention and detection of fraud and other irregularities.

Disclosure of information to Accountants

Each of the persons who are Trustees at the same time when this Trustees’ report is approved has confirmed that:

Approved by order of the members of the Board of Trustees and signed on their behalf by:

Mrs J M D Hirst MBE

Date:

9

THE INSULIN DEPENDENT DIABETES TRUST

REPORT OF THE INDEPENDENT EXAMINER TO THE TRUSTEES OF THE CHARITIABLE COMPANY ON THE ACCOUNTS FOR THE YEAR ENDED 31 DECEMBER 2020

I report to the Trustees on my examination of the accounts of the above charity for the year ended 31 December 2020.

Respective responsibilities of Trustees and Independent Examiner

As the Charity’s Trustees, you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011.

The Trustees consider that the audit requirement of Section 144(1) of the Charities Act 2011 (the Act) does not apply, and that there is no requirement in the memorandum and articles of the charity for the conducting of an audit, and that the accounts do not require an audit in accordance with Part 16 of the Companies Act 2006 and that no member or members have requested an audit pursuant to section 476 of the Companies Act 2006. As a consequence, the Trustees have elected that the financial statements be subject to independent examination.

I report in respect of my examination on the Trust’s accounts carried out under Section 145 of the 2011 Act and in carrying out my examination, I have followed all the applicable Directions given by the Charity Commission under Section 145 950 9B0 of the Act.

Basis of Examiner’ Statement and scope of work undertaken

The Charity’s gross income exceeded £250,000 and I am qualified to undertake the examination by being a qualified member of AAT.

No matters have come to my attention in connection with the examination which gives me cause to believe that the accounting records were kept in accordance with Section 130 of the Charities Act or the accounts did not accord with the accounting records or the accounts did not comply with the applicable requirements concerning the form and contents of accounts set out in the Charities Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.

Mrs T Loughran – Independent Examiner FMAAT, MIP

1 Washington Street Kingsthorpe Northampton NN2 6NN

This report was signed on 30 August 2021

10

THE INSULIN DEPENDENT DIABETES TRUST

STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2020

Restricted Unrestricted Total Total
funds funds funds funds
2020 2020 2020 2019
Note £ £ £ £
Income from:
Donations & Legacies 3 0 368,771 368,771 1,152,054
Other trading activities 4 0 3,068 3,068 5,909
Investments 5 0 685 685 13,924
Other income 6 0 38,213 38,213 36,964
__ __ __ __
Total income 0 410,737 410,737 1,208,842
__ __ __ __
Expenditure on:
Raising funds 0 19,107 19,107 24,020
Charitable activities and
governance costs 7 137,532 389,205 526,737 645,068
__ __ __ __
Total expenditure 137,532 408,312 545,844 669,088
__ __ __ __
Net gains (losses) on
Investments 0 158,074 158,074 217,334
__ __ __ __
Net movement in funds (137,532) 160,499 22,967 757,088
__ __ __ __
Reconciliation of funds:
Total funds brought forward 874,365 2,030,783 2,905,148 2,148,060
Net movement in funds (137,532) 160,499 22,967 757,088
__ __ __ __
Total funds carried forward 736,833 2,191,282 2,928,115 2,905,148
__ __ __ __

The Statement of financial activities includes all gains and losses recognised in the year.

The notes on pages 13 to 25 form part of these financial statement.

11

THE INSULIN DEPENDENT DIABETES TRUST

BALANCE SHEET AS AT 31 BALANCE SHEET AS AT 31 DECEMBER 2020
2020 2019
Note £ £
Fixed assets
Tangible assets 12 358,034 358,528
Investments 13 1,825,076 1,679,412
__ __
Total fixed assets 2,183,110 2,037,940
Current assets
Stocks 14 10,092 10,138
Debtors 8,800 0
Investments 15 145,334 142,261
Cash at bank and in hand 601,151 725,413
__
__
Total current assets 765,377 877,812
Creditors: amounts falling
due within one year 16 (32,054) (22,286)
__
__
Net current assets 733,323 855,526
__ __
Total assets less current liabilities 2,916,433 2,893,466
__ __
Total net assets 2,916,433 2,893,466
__ __
Charity funds
Restricted funds 18 736,833 874,365
Unrestricted funds 18 2,179,600 2,019,101
__ __
Total charity funds 2,916,433 2,893,466
__ __

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

The financial statements were approved and authorised for issue by the Trustees and signed on their behalf by:

Mrs J M D Hirst MBE

Date:

12

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

1. General information

The charity is a company limited by guarantee, registered in England and Wales. The registered office is as noted in the Trustee’s Report.

2. Accounting policies

2.1 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and the Republic of Ireland (FRS 102) (Issued in October 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

The Insulin Dependent Diabetes Trust meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

2.2 Going concern

The operations and business activities of the Charity has been impacted by the recent COVID-19 outbreak. However, after making appropriate enquiries, the Trustees have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.

2.3 Income

All income is recognised once the Company has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

The recognition of income from legacies is dependent on establishing entitlement, the probability of receipt and the ability to estimate with sufficient accuracy the amount receivable. Evidence of entitlement to a legacy exists when the Company has sufficient evidence that a gift has been left to them (through knowledge of the existence of a valid Will and the death of the benefactor) and the executor is satisfied that the property in question will not be required to satisfy claims in the estate. Receipt of a legacy must be recognised when it is probable that it will be received and the fair value of the amount receivable, which will generally be the expected cash amount to be distributed to the Company, can be reliably measured.

Income tax recoverable in relation to investment income is recognised at the time the investment income is receivable.

Other income is recognised in the period in which it is receivable and to the extent the goods have been provided or on completion of the service.

13

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

2.4 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party. It is probable that a transfer of economic benefit will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is classified by activity. The costs of each activity are made up to the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributed to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources.

Expenditure on raising funds includes all expenditure incurred by the Company to raise funds for its charitable purposes and includes costs of all fundraising activities, events and non-charitable trading.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Company’s objectives, as well as any associated support costs.

All expenditure is inclusive of irrecoverable VAT.

2.5 Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Company; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.

2.6 Tangible fixed assets and depreciation

Tangible fixed assets costing £1,000 or more are capitalised and recognised when future economic benefits are probable and the cost or value of the asset can be measured reliably.

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. All costs incurred to bring a tangible fixed asset into its intended working condition should be included in the measurement of cost.

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives.

Depreciation is provided on the following basis:

Office Equipment - 20% reducing balance Computer equipment - 20% reducing balance

The freehold property is not depreciated as the depreciation would be immaterial.

2.7 Investments

Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance Sheet date, unless the value cannot be measured reliably in which case it is measured at cost less

14

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘Gains/(Losses) on investments’ in the Statement of financial activities.

2.8 Stocks

Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Costs includes all direct costs.

2.9 Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

2.10 Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Company anticipated it will pay to settle the debt or the amount it has received as advanced payments for the goods and services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation.

2.11 Financial instruments

The Company only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

2.12 Pensions

The Company operates a defined contribution pension scheme and the pension charge represents the amounts payable by the Company to the fund in respect of the year.

2.13 Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Company and which have not been designated for other purposes.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Company for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Investment income, gains and losses are allocated to the appropriate fund.

15

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

3. Income from donations and legacies

Unrestricted Total Total
funds funds funds
2020 2020 2019
£ £ £
Legacies
A M G Devere-Holloway 1,000 1,000 0
J A Moore 50,918 50,918 438,759
E Harrower 15,000 15,000 218,910
M C Broker 14,417 14,417 342,412
A Skelton 4,986 4,986 28,385
J B Jennings 3,488 3,488 41,259
S G Litchfield 2,501 2,501 0
P Jackson 200,000 200,000 0
__ __ __
Subtotal detailed disclosure 292,310 292,310 1,055,725
__ __ __
Donations 74,598 74,598 69,791
Legacies under £1,000 1,863 1,863 26,529
__ __ __
Subtotal 76,461 76,461 96,320
__ __ __
Total 368,771 368,771 1,152,045
__ __ __

4. Income from other trading activities

Income from fundraising events

Unrestricted Total Total
funds funds funds
2020 2020 2019
£ £ £
Fundraising 3,068 3,068 5,909
__ __ __

16

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

5. Investment income

Unrestricted Total Total
funds funds funds
2020 2020 2019
£ £ £
Investment income 685 685 13,924
__ __ __

6. Other income resources

Unrestricted Unrestricted Total Total
funds funds funds
2020 2020 2019
£ £ £
Sales of goods and lottery 38,213 38,213 36,964
__ __ __
Analysis of expenditure on charitable activities
Summary by fund type
Restricted Unrestricted Total Total
funds funds funds funds
2020 2020 2020 2019
£ £ £ £
Charitable activities 137,532 389,205 526,737 645,068
__ __ __ __
__ __ __
Total 2019 156,113 488,955 645,068
__ __ __

7. Analysis of expenditure on charitable activities

17

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

8. Analysis of expenditure by activities

Activities
Undertaken Support Total Total
Directly costs funds funds
2020 2020 2020 2019
£ £ £ £
Charitable activities 465,879 60,858 526,737 645,068
__ __ __ __
__ __ __
Total 2019 552,599 92,471 645,068
__ __ __

Analysis of direct costs

Charitable Total Total
Activities funds funds
2020 2020 2019
£ £ £
Staff Costs 98,223 98,223 105,152
Research grants 137,532 137,532 156,113
Temporary staff 0 0 1,198
Travel and subsistence 444 444 3,673
Marketing and advertising 61,344 61,344 69,733
Research and editorial costs 42,468 42,468 54,062
Health and Safety 825 825 730
Professional indemnity costs 1,485 1,485 1,022
Website and IT 23,865 23,865 22,712
Printing costs 42,087 42,087 59,229
Direct Mail 51,119 51,119 51,608
Conference, information and meeting costs 2,889 2,889 25,451
Legal and professional 0 0 1,914
Charitable activities 3,598 3,598 0
__ __ __
465,879 465,879 552,597
__ __ __

18

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

Analysis of support costs
Charitable Total Total
Activities funds funds
2020 2020 2019
£ £ £
Staff costs 12,086 12,086 19,147
Depreciation 1,238 1,238 1,423
Legal and professional 16,050 16,050 26,977
Telephone and internet 660 660 685
Printing, postage and stationery 18,808 18,808 24,221
HR Training and welfare – staff 3,600 3,600 817
Rates and water charges 1,828 1,828 1,761
Bank Charges 756 756 1,219
Cleaning and waste management 655 655 1,001
Premises repairs and renewals 5,177 5,177 15,220
__ __ __
60,858 60,858 92,471
__ __ __
9. Auditors’ remuneration
2020 2019
£ £
Fees payable to the Company’s auditors for the audit of
the Company’s annual accounts 0 9,000
__ __
10. Staff costs
2020 2019
£ £
Wages and salaries 110,309 124,217
Social security costs 6,397 8,567
Contribution to defined contribution pension schemes 3,598 3,198
__ __
120,304 135,982
__ __

19

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

The average number of persons employed by the Company during the year was as follows:

2020 2019
No. No.
Employees 4 5
__ __

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:

2020 2019
No. No.
In the band £60,001 to £70,000 0 1
__ __

11. Trustees’ remuneration and expenses

With the agreement of the Charities Commission Mrs J M D Hirst’s remuneration is for extensive research, publications and editorial work. Mrs Hirst attends meetings, conferences and seminars on behalf of the Charity to lecture on the rights to retain a choice of insulins. Her continued contribution to the work of the Charity is invaluable. The value of the Trustees’ remuneration and other benefits is fees of £25,263 (2019 £44,150).

During the year ended 31 December 2020, no Trustee expenses have been incurred ( 2019 - £NIL )

20

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

12. Tangible fixed assets

Freehold Office
Property equipment Total
£ £ £
Cost or valuation
At 1 January 2020 351,842 49,906 401,748
Additions 0 744 744
__ __ __
At 31 December 2020 351,842 50,650 402,492
__ __ __
Depreciation
At 1 January 2020 0 43,220 43,220
Charge for the year 0 1,238 1,238
__ __ __
At 31 December 2020 0 44,458 44,458
__ __ __
Net book value
At 31 December 2020 351,842 6,192 358,034
__ __ __
At 31 December 2019 351,842 6,686 358,528
__ __ __
13. Fixed asset investments
Unlisted
Investments
£
Cost or valuation
Transfers between classes 1,825,076
__
At 31 December 2020 1,825,076
__
Net book value
At 31 December 2020 1,825,076
__

Investment portfolios have previously been treated as current asset investments.

21

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

14. Stocks

2020 2019
£ £
Finished goods and goods for resale 10,092 10,138
__ __
Current asset investments
2020 2019
£ £
Unlisted investment 0 0
Unlisted investments (liquid) 145,334 142,261
__ __
145,334 142,261
__ __
Creditors: Amounts falling due within one year
2020 2019
£ £
Trade creditors 18,139 9,152
Other taxation and social security 7,000 2,835
Other creditors 1,048 660
Accruals and deferred income 5,867 9,639
__ __
32,054 22,286
__ __

15. Current asset investments

16. Creditors: Amounts falling due within one year

22

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

17. Statement of funds

Statement of funds – current year

Balance at
Balance at 31
1 January Gains/ December
2020 Income Expenditure (Losses) 2020
£ £ £ £ £
Unrestricted funds
Reserves 2,030,783 410,737 (419,994) 158,074 2,179,600
__ __ __ __ __
Restricted funds
Restricted funds 874,365 0 (137,532) 0 736,833
__ __ __ __ __
Total of funds 2,905,148 410,737 (557,526) 158,074 2,916,433
__ __ __ __ __

Statement of funds – prior year

Balance at
Balance at 31
1 January Gains/ December
2019 Income Expenditure (Losses) 2019
£ £ £ £ £
Unrestricted funds
Reserves 1,117,582 1,208,842 (524,657) 217,334 2,019,101
____ ____ ____ ____ ____
Restricted funds
Restricted funds 1,030,478 0 (156,113) 0 874,365
____ ____ ____ ____ ____
Total of funds 2,148,060 1,208,842 (680,770) 217,334 2,893,466
__ __ __ __ __

23

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

18. Analysis of net assets between funds

Analysis of net assets between funds – current year

Restricted Unrestricted Total
funds funds funds
2020 2020 2020
£ £ £
Tangible fixed assets 0 358,034 358,034
Fixed asset investments 0 1,825,076 1,825,076
Current assets 736,833 28,544 765,377
Creditors due within one year 0 (32,054) (32,054)
__ __ __
Total 736,833 2,179,600 2,916,433
__ __ __
Analysis of net assets between funds – prior year
Restricted Unrestricted Total
funds funds funds
2019 2019 2019
£ £ £
Tangible fixed assets 0 358,528 358,528
Fixed asset investments 0 1,679,412 1,679,412
Current assets 874,365 3,447 877,812
Creditors due within one year 0 (22,286) (22,286)
__ __ __
Total 874,365 2,019,101 2,893,466
__ __ __
19. Reconciliation of net movement in funds to net cash flow from operating activities
2020 2019
£ £
Net income for the year (as per Statement of Financial Activities) 22,967 757,088
__ __
Adjustments for:
Depreciation charges 1,238 1,423
Gains/(losses) on investments (158,074) (217,334)
Decrease/(increase) in stocks 46 (352)
Increase/(decrease) in creditors 9,768 (5,665)
__ __
Net cash provided by operating activities (124,055) 535,160
__ __

24

THE INSULIN DEPENDENT DIABETES TRUST

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020

20. Analysis of cash and cash equivalents

2020 2019
£ £
Cash in hand 601,151 725,413
__ __
Total cash and cash equivalents 601,151 725,413
__ __
Analysis of changes in net debt
At 1 Other non- At 31
January Cash cash December
2020 flows changes 2020
£ £ £ £
Cash at bank and in hand 725,413 (124,262) 0 601,151
Liquid investments 142,261 0 (3,073) 139,188
__ __ __ __
867,674 (124,262) (3,073) 740,339
__ __ __ __

21. Analysis of changes in net debt

22. Pension commitments

The Charity operates a defined contribution pension scheme. The assets of the scheme are held separately from those of the Charity in an independently administered fund. The pension cost charge represents contributions payable by the Charity to the fund and amounted to £3,598 (2019 - £3,198).

23. Post Balance Sheet events

The Charity has been impacted post year end as a result of COVID-19. Currently the extent of the financial impact is uncertain but the Charity is confident that it has the sufficient reserves and resources to continue operating and therefore the Trustees consider it to be a going concern.

25